Blog

»  Posts By    

Prime Therapeutics Continues Efforts Against Physician Dispensing

A year ago, Prime Therapeutics (Prime) announced that it would no longer accept new Physician Dispensing entities into their pharmacy networks starting on or around January 29, 2018. At the time, Prime had not terminated any Dispensing Physician entities that were already participating providers in its pharmacy networks and had made overtures that their participation would remain unaffected. Many Physician Dispensing entities nevertheless braced for aggressive audits and investigations, out...

Frier Levitt Successfully Reduces PBM Audit by $392K for New York-Based Pharmacy

A New York-based pharmacy was facing a $400k recoupment following a PBM invoice reconciliation audit where the PBM had alleged the pharmacy did not have proper inventory. This is not an uncommon occurrence as PBMs often conduct invoice reconciliation audits to compare quantities of medications and the quantities billed. After submitting invoice documentation and other supporting materials, Frier Levitt successfully demonstrated that the pharmacy had maintained sufficient inventory at all...

FDA Withdraws Proposed Rule for Generic Manufacturers

In a major development in the pharmaceutical industry, the FDA recently announced that it is withdrawing a proposed rule requiring generic drug manufacturers to independently update their drug labels with new information. Currently, generic manufacturers who hold Abbreviated New Drug Application (ANDA) are prohibited from making unilateral changes to their label prior to the corresponding branded Referenced Listed Drug (RLD) manufacturers make changes in the brand drug label. The proposed...

PHARMACY ALERT: PSAOs Amending Pharmacy Participation Agreements

Recently, pharmacies have been finding that Pharmacy Services Administrative Organizations (PSAOs) are amending their pharmacy agreements. Pharmacies should closely review these revisions to determine how their rights may change under the new contract amendments. Reviewing there visions is made even more important due to numerous PSAOs seeking to withhold moneys for GER and DIR reconciliations at the close of 2018. Often, PSAO pharmacy amendments become binding if a pharmacy does...

Florida Attorney General Brings Action Against CVS and Walgreens for Role in Opioid Crisis

Florida is suing CVS and Walgreens for allegedly contributing to the opioid crisis. CVS and Walgreens have been added as defendants, among manufacturers and distributors, in a lawsuit brought by Florida Attorney General. Apart from the manufacturers, the lawsuit alleges that CVS and Walgreens have violated their duties under state law not only in their capacity as distributor but also dispensing pharmacies. The suit further alleges that CVS and Walgreens...
12